Hepatitis C: from discovery to cure

ConclusionThe battle against hepatitis C is destined to be recorded in history as one of science's remarkable success. Although the revolutionary direct‐antiviral agents (DAAs) are able to cure more than 95% of HCV patients, access to diagnosis and therapy remains improved. More efforts should be made to promote HCV screening, treatment delivery and vaccine development.

Source: ISBT Science Series - November 1, 2017 Category: Hematology Authors: Y. Li, S. Li, X. Duan, C. Yang, M. Xu, L. Chen Tags: Congress Review Source Type: research